Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, potentially decreasing overall nutrient intake
This dosing strategy means that the duration of treatment can also vary, but it is usually meant to be long term
Como tantas veces sucede en medicina, todo surgi de una forma casual, al ver que los frmacos antidiabticos agonistas GLP-1, causaban una prdida de peso considerable, que adems ayudaba al control de la diabetes tipo II
J Clin Endocrinol Metab 100(8):29092917
Similar Peptides Tirzepatide For weight loss, glucose control, and cardiometabolic benefits
Introducing semaglutidea medication that doesnt just help lower blood sugar but also brings a few impressive perks along the way